Precision Biosensor Inc
KOSDAQ:335810
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Precision Biosensor Inc
Cash Equivalents
Precision Biosensor Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Precision Biosensor Inc
KOSDAQ:335810
|
Cash Equivalents
₩1.7B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Cash Equivalents
₩48.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
SD Biosensor Inc
KRX:137310
|
Cash Equivalents
₩177.4B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cash Equivalents
₩38.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Cash Equivalents
₩41B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
25%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cash Equivalents
₩60.7B
|
CAGR 3-Years
54%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Precision Biosensor Inc
Glance View
Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.
See Also
What is Precision Biosensor Inc's Cash Equivalents?
Cash Equivalents
1.7B
KRW
Based on the financial report for Dec 31, 2024, Precision Biosensor Inc's Cash Equivalents amounts to 1.7B KRW.
What is Precision Biosensor Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
57%
Over the last year, the Cash Equivalents growth was -29%. The average annual Cash Equivalents growth rates for Precision Biosensor Inc have been -32% over the past three years , 57% over the past five years .
